1-3 of 3
Eik Vettorazzi, MSc
Close
Sort by
Journal Articles

Expression of Novel Immune Checkpoint Molecules PVR and PVRL2 Confers a Negative Prognosis to Patients with Acute Myeloid Leukemia and Their Blockade Augments T-Cell Mediated Lysis of AML Cells Alone or in Combination with the BiTE ® Antibody Construct AMG 330

Hauke Stamm, MSc, Felix Klingler, cand. MD, Daniela Pende, MD, Eik Vettorazzi, MSc, Michael Heuser, MD, Ulrike Mock, PhD, Carsten Bokemeyer, MD, Roman Kischel, MD, Sabine Stienen, PhD, Matthias Friedrich, PhD, Michael Lutteropp, PhD, Dirk Nagorsen, MD, Jasmin Wellbrock, PhD, Walter Fiedler, MD
Journal: Blood
Blood (2015) 126 (23): 789.
https://doi.org/10.1182/blood.V126.23.789.789
Published: 2015
Journal Articles

Expression of Gli2, a Downstream Mediator of the Activated Hedgehog Pathway, Represents a Negative Prognostic Marker in AML,

Walter Fiedler, M.D., Gabi Vohwinkel, MSc, Juergen Krauter, MD, Eik Vettorazzi, MSc, Sonja Loges, M.D., Ph.D., Livia Fuhrmann, Patrizia Seyfert, Carsten Bokemeyer, M.D., Jasmin Wellbrock, PhD
Journal: Blood
Blood (2011) 118 (21): 3535.
https://doi.org/10.1182/blood.V118.21.3535.3535
Published: 2011
Journal Articles

Expression of TGF-β Superfamily Receptor ALK-5 Is Associated with Decreased Overall Survival of AML Patients Receiving Standard AML Chemotherapy.

Jasmin Otten, MSc, Lisa Schmitz, Eik Vettorazzi, MSc, Alexander Schultze, MSc, Jürgen Krauter, MD, Carsten Bokemeyer, MD, Walter Fiedler, MD
Journal: Blood
Blood (2009) 114 (22): 1604.
https://doi.org/10.1182/blood.V114.22.1604.1604
Published: 2009